Hussien Marwa Tet al.’s study demonstrated that the low expression of DAXX was associated with the poor prognosis in breast cancer, indicating that the mechanism-mediated by DAXX as a target may have the potential to treat different types of cancer (32). This evidence concerns the gene DAXX and breast carcinoma.